A promising new malaria drug target has been identified in a family of proteins in a malaria-causing parasite.

Researchers from the Francis Crick Institute and the Gulbenkian Institute for Molecular Medicine (GIMM) have shown that the ...

Malaria continues to cause significant morbidity and mortality worldwide, with over 200 million cases and approximately ...

Mosquitoes exposed to the newly developed compounds show reduced malarial parasite growth even when infected four days later.